Solventum Corporation Common Stock (NY:SOLV)

87.86 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Solventum Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know

May 12, 2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...

Via StockStory

Stay informed with the top movers within the S&P500 index on Friday. ↗

May 09, 2025

Get insights into the S&P500 index performance on Friday. Explore the top gainers and losers within the S&P500 index in today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

May 09, 2025

Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

What Analysts Are Saying About Solventum Stock ↗

February 28, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Solventum (NYSE:SOLV) Exceeds Q1 Expectations

May 08, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) announced better-than-expected revenue in Q1 CY2025, with sales up 2.7% year on year to $2.07 billion. Its non-GAAP profit of $1.34 per share was...

Via StockStory

Wall Street Mixed Ahead Of Fed Meeting, Alphabet Sinks: What's Driving Markets Wednesday? ↗

May 07, 2025

U.S. stocks traded mixed at midday Wednesday, as investors remained cautious ahead of the Federal Reserve’s upcoming policy decision, with Chair Jerome Powell set to speak at 2:30 p.m. ET.

Via Benzinga

Topics Economy

Solventum Earnings: What To Look For From SOLV

May 07, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) will be reporting earnings tomorrow after market close. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

7 Analysts Assess Solventum: What You Need To Know ↗

April 30, 2025

Via Benzinga

3 Cash-Producing Stocks Walking a Fine Line

April 27, 2025

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Alpha Buying: Big Oil Becomes Ground Zero for Activist Investing in 2025 ↗

April 24, 2025

Via Benzinga

Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty ↗

April 23, 2025

Thermo Fisher topped Q1 estimates with $5.15 EPS and $10.36 billion revenue, boosted by diagnostics and life sciences growth.

Via Benzinga

Which S&P500 stocks have an unusual volume on Thursday? ↗

April 03, 2025

Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below.

Via Chartmill

Surgical Equipment & Consumables - Diversified Stocks Q4 Recap: Benchmarking STERIS (NYSE:STE)

March 28, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including STERIS...

Via StockStory

Topics Artificial Intelligence Economy

Reflecting On Surgical Equipment & Consumables - Diversified Stocks’ Q4 Earnings: Zimmer Biomet (NYSE:ZBH)

March 24, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Zimmer Biomet (NYSE:ZBH) and the best and...

Via StockStory

Topics Artificial Intelligence Economy

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy ↗

March 21, 2025

Solventum detailed its 2025-2028 growth strategy, reaffirmed its 2025 guidance, and reported Q4 earnings that topped expectations with strong sales and EPS.

Via Benzinga

Q4 Earnings Outperformers: Solventum (NYSE:SOLV) And The Rest Of The Surgical Equipment & Consumables - Diversified Stocks

March 21, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared...

Via StockStory

Topics Artificial Intelligence Economy

Solventum (SOLV): Buy, Sell, or Hold Post Q4 Earnings?

March 18, 2025

Solventum has been treading water for the past six months, recording a small return of 2.6% while holding steady at $74.01.

Via StockStory

BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group

March 10, 2025

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (NYSE:BDX)...

Via StockStory

Topics Artificial Intelligence Economy

Here's What 3M's Big News Means to Investors ↗

March 05, 2025

Via The Motley Fool

Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)

March 05, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (NYSE:CNMD) and the best and worst...

Via StockStory

Topics Artificial Intelligence Economy

Is 3M Stock a Buy Now? ↗

March 01, 2025

The manufacturing conglomerate is slowly turning a corner.

Via The Motley Fool

Explore the top gainers and losers within the S&P500 index in today's session. ↗

February 28, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Why Solventum (SOLV) Stock Is Down Today

February 28, 2025

Shares of healthcare solutions provider Solventum (NYSE:SOLV) fell 6.5% in the morning session after the company reported weak fourth quarter results: its full-year EPS guidance missed. On the other...

Via StockStory

Topics Initial Public Offering

Friday's session: top gainers and losers in the S&P500 index ↗

February 28, 2025

Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Friday.

Via Chartmill

Which S&P500 stocks are gapping on Friday? ↗

February 28, 2025

Curious about the S&P500 stocks that are gapping on Friday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Friday's pre-market session: top gainers and losers in the S&P500 index ↗

February 28, 2025

Stay updated with the S&P500 stocks that are on the move in today's pre-market session.

Via Chartmill

Solventum: Q4 EPS Beats, Cash Flow Dips ↗

February 28, 2025

Solventum surpassed fourth-quarter revenue and earnings expectations while facing challenges in segments and regulatory pressures.

Via The Motley Fool

Solventum’s (NYSE:SOLV) Q4 Sales Top Estimates

February 27, 2025

Healthcare solutions provider Solventum (NYSE:SOLV) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $2.07 billion. Its non-GAAP profit of $1.41 per...

Via StockStory

Topics Artificial Intelligence Economy

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.